Evolve Business Intelligence has published a research report on the Global Negative Pressure Wound Therapy Market, 2023–2033. The global Negative Pressure Wound Therapy market is projected to exhibit a CAGR of around 6.4% during the forecast period of 2023 to 2033.
Evolve Business Intelligence has recognized the following companies as the key players in the global Negative Pressure Wound Therapy Market: ATMOS MedizinTechnik GmbH & Co. KG, Cardinal Health., ConvaTec Group Plc., DeRoyal Industries, Inc., Devon International Group, Investor AB (Mölnlycke Health Care AB), Olle Larsson Holding AG (Medela AG), Smith & Nephew Plc., and Talley Group Ltd.
The Negative Pressure Wound Therapy market is projected to be valued at USD 204.36 Billion by 2033, recording a CAGR of around 6.4% during the forecast period. Negative Pressure Wound Therapy (NPWT) is a medical treatment technique that uses a vacuum or negative pressure to promote the healing of chronic and complex wounds. This technique involves the use of a sealed wound dressing that is connected to a vacuum pump, which creates negative pressure around the wound site, promoting wound healing by reducing edema, increasing blood flow, and removing excess fluid and bacteria from the wound.
The global NPWT market has been significantly impacted by the COVID-19 pandemic. The pandemic has led to an increase in the number of patients with chronic and complex wounds, as well as a strain on healthcare systems around the world. The pandemic has also disrupted supply chains, leading to shortages of NPWT devices and other medical equipment.
The global Negative Pressure Wound Therapy market has been segmented based on Type, Indication, End-user, and region.
Based on Type, the Negative Pressure Wound Therapy market is segmented based on Conventional NPWT, and Single-use NPWT. The conventional NPWT segment is expected to hold the largest share of the market. Conventional NPWT devices are widely used in hospitals and clinics for the management of chronic wounds, as they are effective and cost-efficient.
Based on Indication, the global Negative Pressure Wound Therapy market has been divided into Diabetic Foot Ulcers, Pressure Ulcers, Burns & Trauma, and Others. the diabetic foot ulcers segment is expected to hold the largest share of the market. Diabetic foot ulcers are a common complication of diabetes, and they require specialized and prolonged care, driving the demand for NPWT devices.
Based on End-user, the global Negative Pressure Wound Therapy market has been divided into Hospitals, Clinics, Homecare Settings, and Others. the hospital’s segment is expected to hold the largest share of the market. Hospitals are the primary end-users of NPWT devices, as they are equipped with specialized wound care centers and have a higher patient volume.
The Negative Pressure Wound Therapy market is divided into six regions: North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. In North America, the high prevalence of chronic diseases, the aging population, and the well-established healthcare infrastructure have contributed to the growth of the NPWT market. However, in Asia-Pacific, the market is being driven by factors such as the increasing prevalence of chronic diseases and an aging population, as well as rising demand for advanced wound care treatments. The Asia-Pacific region has a large population, with China and India being two of the most populous countries in the world. The region is also experiencing a rise in chronic diseases such as diabetes, which can lead to non-healing wounds that require advanced wound care treatments like NPWT. As a result, the region presents significant growth opportunities for the NPWT market.